The anti-heart failure drugs, such as angiotensin‐converting enzyme inhibitors [117], angiotensin receptor blockers [118], beta‐blockers [119] and mineralocorticoid receptor antagonists [120] have been tried in heart failure patients with T2D. This evidence concerns the gene ACE and heart failure.